Genomic Blueprint for Rare Cancers - Whole Exome Sequencing (WES) for Rare Malignancies

A sophisticated laboratory test analyzing the entire exome sequence to detect rare genetic mutations linked to malignancies. It aids clinicians in identifying precise therapeutic targets for atypical cancers.